Compare CYTK & MSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | MSA |
|---|---|---|
| Founded | 1997 | 1914 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.5B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | MSA |
|---|---|---|
| Price | $68.45 | $161.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $77.87 | ★ $188.20 |
| AVG Volume (30 Days) | ★ 1.9M | 215.3K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ 3.07 |
| EPS | N/A | ★ 7.10 |
| Revenue | $87,211,000.00 | ★ $1,863,597,000.00 |
| Revenue This Year | $363.61 | $4.58 |
| Revenue Next Year | $64.33 | $5.71 |
| P/E Ratio | ★ N/A | $22.71 |
| Revenue Growth | ★ 2609.26 | 3.31 |
| 52 Week Low | $29.31 | $127.86 |
| 52 Week High | $69.33 | $182.86 |
| Indicator | CYTK | MSA |
|---|---|---|
| Relative Strength Index (RSI) | 62.93 | 52.43 |
| Support Level | $59.85 | $153.04 |
| Resistance Level | $67.98 | $162.01 |
| Average True Range (ATR) | 2.72 | 3.21 |
| MACD | 0.13 | 0.87 |
| Stochastic Oscillator | 91.35 | 94.59 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.